Patents/Assignees

Retension Pharmaceuticals, Inc.

1 patent in portfolio

US12258350utility2025
Crystalline Forms of 4-ethoxy-n-(2-methoxyethyl)-n-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5, 1-f][1,2,4]triazin-2-yl)benzenesulfonamide
0 cites